Stockreport

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company's portfolio -Antibiotic is primarily used for chronic Pseudomonas a [Read more]